Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

129 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase I-II study to determine the maximum tolerated infusion rate of rituximab with special emphasis on monitoring the effect of rituximab on cardiac function.
Siano M, Lerch E, Negretti L, Zucca E, Rodriguez-Abreu D, Oberson M, Leoncini L, Mora O, Sessa C, Gallino A, Ghielmini M. Siano M, et al. Among authors: ghielmini m. Clin Cancer Res. 2008 Dec 1;14(23):7935-9. doi: 10.1158/1078-0432.CCR-08-1124. Clin Cancer Res. 2008. PMID: 19047125 Clinical Trial.
How I treat mantle cell lymphoma.
Ghielmini M, Zucca E. Ghielmini M, et al. Blood. 2009 Aug 20;114(8):1469-76. doi: 10.1182/blood-2009-02-179739. Epub 2009 Jun 25. Blood. 2009. PMID: 19556426 Free article. Review.
Open questions in the management of mantle cell lymphoma.
Li ZM, Zucca E, Ghielmini M. Li ZM, et al. Among authors: ghielmini m. Cancer Treat Rev. 2013 Oct;39(6):602-9. doi: 10.1016/j.ctrv.2012.12.013. Epub 2013 Feb 13. Cancer Treat Rev. 2013. PMID: 23415066 Review.
Rituximab Maintenance for a Maximum of 5 Years After Single-Agent Rituximab Induction in Follicular Lymphoma: Results of the Randomized Controlled Phase III Trial SAKK 35/03.
Taverna C, Martinelli G, Hitz F, Mingrone W, Pabst T, Cevreska L, Del Giglio A, Vanazzi A, Laszlo D, Raats J, Rauch D, Vorobiof DA, Lohri A, Biaggi Rudolf C, Rondeau S, Rusterholz C, Heijnen IA, Zucca E, Ghielmini M. Taverna C, et al. Among authors: ghielmini m. J Clin Oncol. 2016 Feb 10;34(5):495-500. doi: 10.1200/JCO.2015.61.3968. Epub 2015 Dec 28. J Clin Oncol. 2016. PMID: 26712227 Free PMC article. Clinical Trial.
Rituximab: 13 open questions after 20years of clinical use.
Pavanello F, Zucca E, Ghielmini M. Pavanello F, et al. Among authors: ghielmini m. Cancer Treat Rev. 2017 Feb;53:38-46. doi: 10.1016/j.ctrv.2016.11.015. Epub 2016 Dec 22. Cancer Treat Rev. 2017. PMID: 28056413 Review.
129 results